Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Sunrise Podcast: Avoiding the Pain Points of Getting MedTech to Market, with Adam Jacobs

Getting a medical product to market is no simple task. From conception, to development, to marketing to appeal to audiences worldwide, every step has its speed bumps, and like a speed bump, and put in place for good measure. Quality control for feasibility and engineering tests both play a part in making sure that…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Getting a medical product to market is no simple task. From conception, to development, to marketing to appeal to audiences worldwide, every step has its speed bumps, and like a speed bump, and put in place for good measure. Quality control for feasibility and engineering tests both play a part in making sure that the product is functional, viable, and in many cases, FDA approved.

On today’s episode of The Sunrise Podcast, Adam Jacobs, Chief Technology Officer at Sunrise Labs, reeducates on how products are submitted and certified by the FDA and what kind of things need to be done during product development, including ISO 13485 certification for medical devices.

It’s a long and necessary process, especially when the product needs to be manufactured so that it’s reliable and economically sound for the consumer, but also profitable, and that’s where complications often come in. Many companies may work on a single product for long periods of time and end up not getting exposure, and everyone wants to “get to profitability as quickly as they can,” according to Jacobs.

“We probably have 20 or so projects at any given time, and as CTO I’m lucky and get to be exposed to most of them,” Jacobs said, which also means that he sees the products that weren’t put together well. “Getting a mature vision of what you want it to be is often one of the best things that you can do,” because otherwise medtech companies may have to change their products or production process downstream, an expensive and time-consuming mistake.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @HealthMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512